{"transactions":[{"id":2989430,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":145480,"kind":"person","name":"Friedman Mark J","position":1,"cik":"0001590024","reported_name":"Friedman Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL"}}],"security":"Employee Stock Options (right to buy)","published_at":"2020-11-06T21:12:55.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":109054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4 Amendment is being filed solely to add the Power of Attorney."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest 33% on February 25, 2021 and thereafter 1/36th vest each month."}],"balance_after":109054,"derivative":{"exercise_price":3.27,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":109054},"source":{"system":"sec-edgar","filing":"0001415889-20-002554","document":"form4a-11062020_011144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000141588920002554/form4a-11062020_011144.xml","form_type":"4/A","original_submission_date":"2020-02-27"}},{"id":3243364,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":145480,"kind":"person","name":"Friedman Mark J","position":1,"cik":"0001590024","reported_name":"Friedman Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL"}}],"security":"Employee Stock Options (right to buy)","published_at":"2020-02-28T01:29:07.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":109054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 33% on February 25, 2021 and thereafter 1/36th vest each month."}],"balance_after":109054,"derivative":{"exercise_price":3.27,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":109054},"source":{"system":"sec-edgar","filing":"0001415889-20-000546","document":"form4-02272020_050253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000141588920000546/form4-02272020_050253.xml","form_type":"4"}},{"id":3638242,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":145480,"kind":"person","name":"Friedman Mark J","position":1,"cik":"0001590024","reported_name":"Friedman Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL"}}],"security":"Employee Stock Options (right to buy)","published_at":"2019-02-23T00:35:04.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":89254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 33% on February 21, 2020 and thereafter 1/36th vest each month."}],"balance_after":89254,"derivative":{"exercise_price":3.84,"exercise_date":"2020-02-21","expiration_date":"2029-02-21","underlying":"Common Stock","underlying_shares":89254},"source":{"system":"sec-edgar","filing":"0001415889-19-000219","document":"form4-02222019_040248.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000141588919000219/form4-02222019_040248.xml","form_type":"4"}},{"id":3927525,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":145480,"kind":"person","name":"Friedman Mark J","position":1,"cik":"0001590024","reported_name":"Friedman Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2018-05-17T22:31:15.000Z","date":"2018-05-17","kind":"purchase","acquired":true,"shares":3000,"price":3.6,"value":10800.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001415889-18-000780","document":"form4-05172018_030501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000141588918000780/form4-05172018_030501.xml","form_type":"4"}},{"id":4090859,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":145480,"kind":"person","name":"Friedman Mark J","position":1,"cik":"0001590024","reported_name":"Friedman Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-24T21:22:26.000Z","date":"2018-01-22","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option vest on January 22, 2019, and the remaining shares subject to the option vest in a series of 24 equal monthly installments thereafter on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":5.65,"expiration_date":"2028-01-21","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-18-005110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000120919118005110/doc4.xml","form_type":"4"}},{"id":4421823,"issuer":{"id":4842,"kind":"organization","name":"HERBALIFE LTD."},"owners":[{"id":145480,"kind":"person","name":"Friedman Mark J","position":1,"cik":"0001590024","reported_name":"Friedman Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Appreciation Rights","published_at":"2017-02-28T00:18:05.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":4367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On May 9, 2016, the reporting person was granted an award of 21,834 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 4,367 SARs which will vest on May 9, 2017."}],"balance_after":4367,"derivative":{"exercise_price":62.51,"exercise_date":"2017-05-09","expiration_date":"2026-05-09","underlying":"Common Stock","underlying_shares":4367},"source":{"system":"sec-edgar","filing":"0001209191-17-014995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180262/000120919117014995/doc4.xml","form_type":"4"}},{"id":4421822,"issuer":{"id":4842,"kind":"organization","name":"HERBALIFE LTD."},"owners":[{"id":145480,"kind":"person","name":"Friedman Mark J","position":1,"cik":"0001590024","reported_name":"Friedman Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Appreciation Rights","published_at":"2017-02-28T00:18:05.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":10603,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 2, 2015, the reporting person was granted an award of 53,017 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 10,603 SARs which will vest on March 2, 2017."}],"balance_after":21206,"derivative":{"exercise_price":30.44,"exercise_date":"2017-03-02","expiration_date":"2025-03-02","underlying":"Common Stock","underlying_shares":10603},"source":{"system":"sec-edgar","filing":"0001209191-17-014995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180262/000120919117014995/doc4.xml","form_type":"4"}},{"id":4421821,"issuer":{"id":4842,"kind":"organization","name":"HERBALIFE LTD."},"owners":[{"id":145480,"kind":"person","name":"Friedman Mark J","position":1,"cik":"0001590024","reported_name":"Friedman Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Appreciation Rights","published_at":"2017-02-28T00:18:05.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":15011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On April 30, 2014, the reporting person was granted an award of 25,019 stock appreciation rights (\"SARs\"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the \"Company\") of certain performance criteria for each of fiscal 2014, 2015 and 2016. The performance criteria for 2016 was met, resulting in 15,011 SARs which will vest on April 30, 2017."}],"balance_after":25019,"derivative":{"exercise_price":59.98,"exercise_date":"2017-04-30","expiration_date":"2024-04-30","underlying":"Common Stock","underlying_shares":15011},"source":{"system":"sec-edgar","filing":"0001209191-17-014995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180262/000120919117014995/doc4.xml","form_type":"4"}}]}